Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Vinorelbine

A semi-synthetic vinca alkaloid, obtained in France in the 1980s, approved there in 1989 and in the United States in 1994; it is used for non-small cell lung cancer and breast cancer. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.

Did you know?It was created by pharmacist Pierre Potier and his CNRS team: the same researcher also gave us docetaxel, obtained from the European yew (Taxus baccata).

VinorelbineGo to the active ingredient →
VinorelbineActive ingredientVinorelbineCat. No. P-V050-001CAS 71486-22-1
VindolineImpurityVindolineCat. No. P-V050-015CAS 2182-14-1

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.